Skip to main content
. 2023 Nov 6;14:1241145. doi: 10.3389/fendo.2023.1241145

Table 2.

Participant information at follow-up.

Case Total N%
Alive or Death Alive 71 72 98.6%
Death 1 1.4%
Tumor Recurrence Recurrence 18 69 26.1%
No-recurrence 51 73.9%
Regular Review in Endocrinology Clinic Yes 62 71 87.3%
No 9 12.7%
Clinical Manifestation Headache 5 71 7.0%
Visual Defect 24 33.8%
Polyuria 35 49.3%
Short stature 16 57 28.1%
Obesity 31 54.4%